Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma-Reference-Cited by-同舟云学术

Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma

Published:2017-10-03 Issue:10 Volume:18 Page:816-826
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

May Caitlin D.¹²,Landers Sharon M.¹,Bolshakov Svetlana¹,Ma XiaoYan¹,Ingram Davis R.³,Kivlin Christine M.¹²,Watson Kelsey L.¹,Sannaa Ghadah A. Al³,Bhalla Angela D.¹,Wang Wei-Lien³,Lazar Alexander J.²³^ORCID,Torres Keila E.¹²^ORCID

Affiliation:

1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, USA

3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2017.1373230

Reference64 articles.

1. Romeo S, Bovee JVMG, Jundt G. Undifferentiated high grade pleomorphic sarcoma. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. (eds). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. Lyon: IARC Press; 364-365.

2. The evolving classification of soft tissue tumours: an update based on the new WHO classification

3. Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma

4. Do Radiation-Associated Soft Tissue Sarcomas Have the Same Prognosis As Sporadic Soft Tissue Sarcomas?

5. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma;Frontiers in Genetics;2023-02-16

2. Role of microRNA-34b-5p in cancer and injury: how does it work?;Cancer Cell International;2022-12-01

3. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma;Frontiers in Oncology;2022-11-10

4. The Role of AKT in Soft Tissue Sarcoma: Review and Insights;Molecular Cancer Research;2022-07-07

5. The SKBR3 cell-membrane proteome reveals telltales of aberrant cancer cell proliferation and targets for precision medicine applications;Scientific Reports;2022-06-27